Evidence map›Paper›PMID 29940999›Full record

SynthesisOrphanet journal of rare diseases2018

Thymectomy in nonthymomatous myasthenia gravis - systematic review and meta-analysis.

Antônio J M Cataneo, Gilmar Felisberto, Daniele C Cataneo

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Orphanet journal of rare diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Minimally invasiveJournal of thoracic disease · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Thymectomy in Myasthenia Gravis: A Narrative Review.Saudi journal of medicine & medical sciences
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Antônio J M CataneoDivision of Thoracic Surgery, Department of Surgery, Botucatu School of Medicine, São Paulo State University, UNESP, Botucatu, SP, CEP 18.618-970, Brazil. acataneo@fmb.unesp.br.ORCID 0000-0003-2330-9337
Gilmar FelisbertoPost-Graduation Program General Bases of Surgery, Botucatu School of Medicine, São Paulo State University, UNESP, São Paulo, Brazil.
Daniele C CataneoDivision of Thoracic Surgery, Department of Surgery, Botucatu School of Medicine, São Paulo State University, UNESP, Botucatu, SP, CEP 18.618-970, Brazil.
Universidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of this study is to evaluate by means of a systematic review, the efficacy of thymectomy as compared to medical treatment for non-thymomatous myasthenia gravis (MG).

methodsMedline, Embase, and Lilacs were searched for experimental and observational studies that compared non-surgical (drug therapy) and surgical treatment of non-thymomatous MG (thymectomy performed by the transsternal approach). Inclusion criteria were: studies that compared the two types of treatment and had at least 10 adult patients in each group. Exclusion criteria were articles published before 1970, as well as those that included patients treated before 1950. The outcomes evaluated were: remission, and improvement rates. RevMan 5.3 software provided by the Cochrane Collaboration was used. When the heterogeneity between the studies was greater than 75%, a meta-analysis was not performed according to RevMan guidelines.

resultsThe total number of patients evaluated in 19 articles selected was 5841 (2911 surgical and 2930 non-surgical). Two included randomized clinical trials showed superiority of the surgical treatment over the non-surgical. Four retrospective studies with 379 patients paired by gender, age, and other confounders, also showed superiority of surgical treatment (OR 4.10, 95% CI 2.25 to 7.44; I

conclusionThymectomy may be considered effective in the treatment for non-thymomatous MG, with remission rate higher than for non-surgical treatment.

Indexed as

ThymectomyFemaleHumansMaleMyasthenia GravisDrug therapyMyasthenia gravisThymectomy

Identifiers

PMID29940999
PMCPMC6020196
OpenAlexW2811080023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.